Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Landsittel currently holds 37,313 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Landsittel has been a net seller of BPMC stock. They have purchased $0 and sold $4.4M worth of shares.
Michael Landsittel's most recent insider trade was on Mar 23, 2026, when they sold 37,313 shares at $0.00 per share.
Michael Landsittel serves as Executive at Blueprint Medicines Corp (BPMC). They have executed 36 insider transactions totaling $4.4M over their tenure at the company.
Michael Landsittel holds the position of Executive at Blueprint Medicines Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Michael Landsittel has shown a selling trading pattern, with $0 in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Landsittel was on May 2, 2024, when they sold $1.1M worth of BPMC shares. This transaction involved 10,000 shares at $105.00 per share.
Michael Landsittel currently owns 37,313 shares of Blueprint Medicines Corp (BPMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Landsittel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Landsittel has 36 Form 4 filings on record as an insider at Blueprint Medicines Corp.
Set alerts for Michael Landsittel and 40,000+ other insiders.